Hubei Guangji Pharmaceutical Co Ltd

The company's capital structure is highly leveraged, with a debt-to-equity ratio of 2.15, indicating significant reliance on long-term debt to finance operations. Despite a negative net income of -404.49 million CNY, the company generated positive operating cash flow of 60.43 million CNY, suggesting some operational liquidity. However, the free cash flow is negative at -365.25 million CNY, indicating that capital expenditures and other cash outflows exceed operating cash inflows. Profitability metrics are severely underperforming relative to industry norms. The company's return on equity (ROE) is -61.87%, and return on assets (ROA) is -17.49%, both of which are well below the typical thresholds for pharmaceutical firms. This suggests that the company is not generating returns that justify its cost of capital or asset base. Geographically, the company operates in both domestic and overseas markets, but the financial data does not provide a breakdown of revenue by region or segment. The lack of segmental reporting limits the ability to assess geographic or product concentration risk. The company's growth trajectory is mixed. While the latest actual revenue of 843.83 million CNY is higher than the reported revenue of 623.97 million CNY, the operating income is negative at -443.91 million CNY, indicating a significant decline in profitability. The capital expenditure of -35.64 million CNY suggests some investment in infrastructure, but it is not sufficient to offset the operating losses. Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt, and a low dilution risk, with no significant dilution potential in the near term. The company's liquidity position is further constrained by a current ratio of 0.61, indicating that it has insufficient current assets to cover its current liabilities. Recent events include the latest financial reporting, which shows a significant operating loss and negative net income. No recent filings or transcripts were provided in the input data to indicate strategic shifts or operational changes.